Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - GROSS PROFIT
Gross Profit NVO - Novo Nordisk A/S
196 B
LAST VALUE
29.52%
2 YEAR CAGR
15.84%
5 YEAR CAGR
10.96%
10 YEAR CAGR